Hepatitis B Core-Related Antigen to Indicate High Viral Load: Systematic Review and Meta-Analysis of 10,397 Individual Participants

2017 2017 2017, EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection, J Hepatol, 67, 370, 10.1016/j.jhep.2017.03.021 Terrault, 2018, Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance, Hepatology, 67, 1560, 10.1002/hep.29800 Sarin, 2016, Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update, Hepatol Int, 10, 1, 10.1007/s12072-015-9675-4 Razavi-Shearer, 2018, Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study, Lancet Gastroenterol Hepatol, 3, 383, 10.1016/S2468-1253(18)30056-6 Freiman, 2016, Hepatitis C core antigen testing for diagnosis of hepatitis C virus infection: a systematic review and meta-analysis, Ann Intern Med, 165, 345, 10.7326/M16-0065 Kimura, 2002, Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load, J Clin Microbiol, 40, 439, 10.1128/JCM.40.2.439-445.2002 Ning, 2017, Capsid phosphorylation state and hepadnavirus virion secretion, J Virol, 91, 10.1128/JVI.00092-17 Wong, 2007, Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infection, J Clin Microbiol, 45, 3942, 10.1128/JCM.00366-07 Suzuki, 2009, Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients, J Med Virol, 81, 27, 10.1002/jmv.21339 Maasoumy, 2015, Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D, Clin Microbiol Infect, 21, 606.e1, 10.1016/j.cmi.2015.02.010 Riveiro-Barciela, 2017, Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype, Clin Microbiol Infect, 23, 860, 10.1016/j.cmi.2017.03.003 Shimakawa, 2020, Hepatitis B core-related antigen: an alternative to hepatitis B virus DNA to assess treatment eligibility in Africa, Clin Infect Dis, 70, 1442 Wong, 2017, Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA, Liver Int, 37, 995, 10.1111/liv.13346 Testoni, 2019, Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients, J Hepatol, 70, 615, 10.1016/j.jhep.2018.11.030 Stewart, 2015, Preferred reporting items for a systematic review and meta-analysis of individual participant data: the PRISMA-IPD statement, JAMA, 313, 1657, 10.1001/jama.2015.3656 Whiting, 2011, Quadas-2: a revised tool for the quality assessment of diagnostic accuracy studies, Ann Intern Med, 155, 529, 10.7326/0003-4819-155-8-201110180-00009 Riley, 2010, Meta-analysis of individual participant data: rationale, conduct, and reporting, BMJ, 340, 521, 10.1136/bmj.c221 Alonzo, 2002, Distribution-free ROC analysis using binary regression techniques, Biostatistics, 3, 421, 10.1093/biostatistics/3.3.421 Altman, 2003, Interaction revisited: the difference between two estimates, BMJ, 326, 219, 10.1136/bmj.326.7382.219 Singh, 2015, Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data, Clin Gastroenterol Hepatol, 13, 440, 10.1016/j.cgh.2014.09.046 Tanaka, 2014, Guidelines for avoiding risks resulting from discontinuation of nucleoside/nucleotide analogs in patients with chronic hepatitis B, Hepatol Res, 44, 1, 10.1111/hepr.12108 Mak, 2018, Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection, Aliment Pharmacol Ther, 47, 43, 10.1111/apt.14376 Lai, 2017, Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B, J Hepatol, 66, 275, 10.1016/j.jhep.2016.08.022 Cornberg, 2017, The role of quantitative hepatitis B surface antigen revisited, J Hepatol, 66, 398, 10.1016/j.jhep.2016.08.009 Chen, 2017, Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B, Sci Rep, 7, 1 Chuaypen, 2018, Predictive role of serum HBsAg and HBcrAg kinetics in patients with HBeAg-negative chronic hepatitis B receiving pegylated interferon–based therapy, Clin Microbiol Infect, 24, 10.1016/j.cmi.2017.07.016 Chen, 2019, Serum HBcrAg is better than HBV RNA and HBsAg in reflecting intrahepatic covalently closed circular DNA, J Viral Hepat, 26, 586, 10.1111/jvh.13061 Tada, 2016, HBcrAg is a predictor of hepatocellular carcinoma development: an analysis using time-dependent receiver operating characteristics, J Hepatol, 65, 48, 10.1016/j.jhep.2016.03.013 Tada, 2018, Hepatitis B virus core-related antigen levels predict progression to liver cirrhosis in hepatitis B carriers, J Gastroenterol Hepatol, 33, 918, 10.1111/jgh.13989 Tseng, 2019, High level of hepatitis B core-related antigen associated with increased risk of hepatocellular carcinoma in patients with chronic HBV infection of intermediate viral load, Gastroenterology, 157, 1518, 10.1053/j.gastro.2019.08.028 Ndlovu, 2018, Multidisease testing for HIV and TB using the GeneXpert platform: a feasibility study in rural Zimbabwe, PLoS One, 13, 1, 10.1371/journal.pone.0193577 Lemoine, 2016, Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study, Lancet Glob Health, 4, e559, 10.1016/S2214-109X(16)30130-9 Zhang, 2018, Performance of hepatitis B core-related antigen versus hepatitis B surface antigen and hepatitis B Virus DNA in predicting HBeAg-positive and HBeAg-negative chronic hepatitis, Ann Lab Med, 39, 67, 10.3343/alm.2019.39.1.67 Loggi, 2019, Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B, J Viral Hepat, 26, 568, 10.1111/jvh.13054